The role of prophylaxis of bacterial infections in children with acute leukemia/non-Hodgkin lymphoma

Elio Castagnola

doi:10.4081/pr.2014.5332

The role of prophylaxis of bacterial infections in children with acute leukemia/non-Hodgkin lymphoma

Elio Castagnola

Istituto "Giannina Gaslini"

Research output: Contribution to journal › Article

Abstract

Infections represent a well-known complication of antineoplastic chemotherapy that may cause delay of treatment, with alteration of the antineoplastic program and dose-intensity, or even the death of a patient that could heal from his/her neoplasia. Bacterial infections are a major cause of morbidity and mortality in patients who are neutropenic following chemotherapy for malignancy. Therefore a program of antibiotic prophylaxis for febrile neutropenia may be considered in the management strategy of cancer patients.

Original language	English
Article number	5332
Journal	Pediatric Reports
Volume	6
Issue number	2
DOIs	https://doi.org/10.4081/pr.2014.5332
Publication status	Published - 2014

Keywords

Acute leukemia
Bacterial infections
Non-hodgkin lymphoma
Prophylaxis

ASJC Scopus subject areas

Pediatrics

Access to Document

10.4081/pr.2014.5332

Fingerprint Dive into the research topics of 'The role of prophylaxis of bacterial infections in children with acute leukemia/non-Hodgkin lymphoma'. Together they form a unique fingerprint.

Cite this

Castagnola, E. (2014). The role of prophylaxis of bacterial infections in children with acute leukemia/non-Hodgkin lymphoma. Pediatric Reports, 6(2), [5332]. https://doi.org/10.4081/pr.2014.5332

@article{218cd95f201644e5af970feed7a58123,

title = "The role of prophylaxis of bacterial infections in children with acute leukemia/non-Hodgkin lymphoma",

abstract = "Infections represent a well-known complication of antineoplastic chemotherapy that may cause delay of treatment, with alteration of the antineoplastic program and dose-intensity, or even the death of a patient that could heal from his/her neoplasia. Bacterial infections are a major cause of morbidity and mortality in patients who are neutropenic following chemotherapy for malignancy. Therefore a program of antibiotic prophylaxis for febrile neutropenia may be considered in the management strategy of cancer patients.",

keywords = "Acute leukemia, Bacterial infections, Non-hodgkin lymphoma, Prophylaxis",

author = "Elio Castagnola",

year = "2014",

doi = "10.4081/pr.2014.5332",

language = "English",

volume = "6",

journal = "Pediatric Reports",

issn = "2036-749X",

publisher = "PagePress",

number = "2",

}

TY - JOUR

T1 - The role of prophylaxis of bacterial infections in children with acute leukemia/non-Hodgkin lymphoma

AU - Castagnola, Elio

PY - 2014

Y1 - 2014

N2 - Infections represent a well-known complication of antineoplastic chemotherapy that may cause delay of treatment, with alteration of the antineoplastic program and dose-intensity, or even the death of a patient that could heal from his/her neoplasia. Bacterial infections are a major cause of morbidity and mortality in patients who are neutropenic following chemotherapy for malignancy. Therefore a program of antibiotic prophylaxis for febrile neutropenia may be considered in the management strategy of cancer patients.

AB - Infections represent a well-known complication of antineoplastic chemotherapy that may cause delay of treatment, with alteration of the antineoplastic program and dose-intensity, or even the death of a patient that could heal from his/her neoplasia. Bacterial infections are a major cause of morbidity and mortality in patients who are neutropenic following chemotherapy for malignancy. Therefore a program of antibiotic prophylaxis for febrile neutropenia may be considered in the management strategy of cancer patients.

KW - Acute leukemia

KW - Bacterial infections

KW - Non-hodgkin lymphoma

KW - Prophylaxis

UR - http://www.scopus.com/inward/record.url?scp=84987896622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987896622&partnerID=8YFLogxK

U2 - 10.4081/pr.2014.5332

DO - 10.4081/pr.2014.5332

M3 - Article

AN - SCOPUS:84987896622

VL - 6

JO - Pediatric Reports

JF - Pediatric Reports

SN - 2036-749X

IS - 2

M1 - 5332

ER -